TSHA · Taysha Gene Therapies, Inc.
$5.95
-0.04 (-0.67%)
At close · Aug 14
Market Cap
$2.09B
Shares
325.83M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-11 | Taysha Gene Therapies Second Quarter 2026 Financial Results Conference Call | Earnings call |
| 2026-06-22 | TSHA-102 Rett Syndrome Program Update Conference Call | Conference |
| 2026-06-22 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-05-06 | Taysha Gene Therapies First Quarter 2026 Financial Results Conference Call | Earnings call |
| 2026-03-19 | Taysha Gene Therapies Full-Year 2025 Financial Results Conference Call | Earnings call |
| 2025-11-04 | Taysha Gene Therapies Third Quarter 2025 Financial Results Conference Call | Earnings call |
| 2025-08-12 | Taysha Gene Therapies Second Quarter 2025 Financial Results Conference Call | Earnings call |
Source: https://ir.tayshagtx.com/
Key facts
CIK
1806310
CUSIP
877619106
13F (30d)
210 filings
204 filers
Visit website
Investor relations